Skip to main content
MO

Modus Therapeutics

Stockholm, Sweden
Last funding
$3.0M
Post-IPO EquityJun 2025

Modus Therapeutics is a Swedish drug development company focused on normalizing the lives for patients with Sickle Cell Disease.

Backed byHealthCapKarolinskaRosetta CapitalPraktikerinvestOstersjöstiftelsen

About Modus Therapeutics

How much funding has Modus Therapeutics raised?

Modus Therapeutics has raised $3.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2025.

Who are Modus Therapeutics's investors?

Modus Therapeutics's investors include HealthCap, Karolinska, Rosetta Capital, Praktikerinvest, Ostersjöstiftelsen.

Where is Modus Therapeutics headquartered?

Modus Therapeutics is headquartered in Stockholm, Sweden.

What does Modus Therapeutics do?

Modus Therapeutics is a Swedish drug development company focused on normalizing the lives for patients with Sickle Cell Disease.

What stage is Modus Therapeutics at?

Modus Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Modus Therapeutics — Funding & Investors." VCBacked, June 26, 2025, https://www.vcbacked.co/company/modus-therapeutics. Accessed November 16, 2026.
APA
VCBacked. (2025). Modus Therapeutics — Funding & Investors. Retrieved November 16, 2026, from https://www.vcbacked.co/company/modus-therapeutics
Wikipedia (cite web)
{{cite web |title=Modus Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/modus-therapeutics |website=VCBacked |access-date=November 16, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Modus Therapeutics? Request a listing update

Founder contacts
m***@modustx.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →